Procysbi 
Procedural steps taken and scientific information after the authorisation 
Application 
Scope 
number 
Opinion/ 
Commission 
Product 
Summary 
Notification0F
Decision 
Information 
1 issued on 
Issued1F
2 / 
affected2F
3  
amended 
on 
IB/0038 
B.II.f.1.b.1 - Stability of FP - Extension of the shelf 
26/05/2023 
SmPC 
Product information section 6.3 is updated to reflect the 
life of the finished product - As packaged for sale 
(supported by real time data) 
shelf-life extension of the finished product Procysbi 75 mg 
and 300 mg gastro-resistant granules (EU/1/13/861/003-
004) as packaged for sale from 2 years to 3 years. 
X/0035 
Annex I_2.(c) Change or addition of a new 
23/06/2022 
17/08/2022 
SmPC, 
1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions 
are issued for all other procedures. 
2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The 
CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures. 
3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet). 
Official address  Domenico Scarlattilaan 6  ●  1083 HS Amsterdam  ●  The Netherlands 
Address for visits and deliveries  Refer to www.ema.europa.eu/how-to-find-us  
Send us a question  Go to www.ema.europa.eu/contact   Telephone +31 (0)88 781 6000 
An agency of the European Union 
 
 
 
 
 
 
  
 
 
 
 
 
strength/potency 
Annex I_2.(d) Change or addition of a new 
pharmaceutical form 
Labelling and 
PL 
IA/0037 
A.4 - Administrative change - Change in the name 
12/07/2022 
n/a 
and/or address of a manufacturer or an ASMF holder 
or supplier of the AS, starting material, reagent or 
intermediate used in the manufacture of the AS or 
manufacturer of a novel excipient 
IB/0036 
B.I.a.2.e - Changes in the manufacturing process of 
22/11/2021 
n/a 
the AS - Minor change to the restricted part of an 
ASMF 
N/0034 
Minor change in labelling or package leaflet not 
15/07/2021 
17/08/2022 
PL 
connected with the SPC (Art. 61.3 Notification) 
PSUSA/10573
Periodic Safety Update EU Single assessment - 
10/06/2021 
n/a 
PRAC Recommendation - maintenance 
/202010 
mercaptamine (treatment of nephropathic cystinosis) 
IB/0033/G 
This was an application for a group of variations. 
16/04/2021 
n/a 
B.I.d.1.b.1 - Stability of AS - Change in the storage 
conditions - Change to more restrictive storage 
conditions of the AS 
B.I.d.1.a.4 - Stability of AS - Change in the re-test 
period/storage period - Extension or introduction of a 
re-test period/storage period supported by real time 
data 
B.I.b.z - Change in control of the AS - Other 
variation 
Page 2/13 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N/0031 
Minor change in labelling or package leaflet not 
27/10/2020 
17/08/2022 
PL 
connected with the SPC (Art. 61.3 Notification) 
IA/0030/G 
This was an application for a group of variations. 
19/08/2020 
n/a 
B.II.d.2.a - Change in test procedure for the finished 
product - Minor changes to an approved test 
procedure 
B.II.f.1.e - Stability of FP - Change to an approved 
stability protocol 
IA/0029/G 
This was an application for a group of variations. 
22/06/2020 
n/a 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
IA/0028/G 
This was an application for a group of variations. 
16/01/2020 
n/a 
B.II.b.3.a - Change in the manufacturing process of 
the finished or intermediate product - Minor change 
Page 3/13 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
in the manufacturing process 
B.II.b.3.a - Change in the manufacturing process of 
the finished or intermediate product - Minor change 
in the manufacturing process 
B.II.b.3.a - Change in the manufacturing process of 
the finished or intermediate product - Minor change 
in the manufacturing process 
B.II.b.3.a - Change in the manufacturing process of 
the finished or intermediate product - Minor change 
in the manufacturing process 
IA/0027/G 
This was an application for a group of variations. 
07/11/2019 
n/a 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.II.b.5.a - Change to in-process tests or limits 
applied during the manufacture of the finished 
product - Tightening of in-process limits 
B.II.d.2.a - Change in test procedure for the finished 
product - Minor changes to an approved test 
procedure 
B.II.d.2.a - Change in test procedure for the finished 
product - Minor changes to an approved test 
procedure 
B.II.d.2.a - Change in test procedure for the finished 
product - Minor changes to an approved test 
procedure 
Page 4/13 
 
 
 
 
 
 
 
 
 
B.II.d.2.f - Change in test procedure for the finished 
product - To reflect compliance with the Ph. Eur. and 
remove reference to the outdated internal test 
method and test method number 
IB/0026 
B.II.f.1.b.1 - Stability of FP - Extension of the shelf 
11/09/2019 
29/10/2019 
SmPC 
life of the finished product - As packaged for sale 
(supported by real time data) 
IAIN/0025/G 
This was an application for a group of variations. 
05/04/2019 
29/10/2019 
Annex II and 
PL 
A.7 - Administrative change - Deletion of 
manufacturing sites 
A.7 - Administrative change - Deletion of 
manufacturing sites 
B.II.b.2.c.2 - Change to importer, batch release 
arrangements and quality control testing of the FP - 
Including batch control/testing 
N/0024 
Minor change in labelling or package leaflet not 
20/12/2018 
29/10/2019 
PL 
connected with the SPC (Art. 61.3 Notification) 
IAIN/0023/G 
This was an application for a group of variations. 
13/11/2018 
29/10/2019 
Annex II and 
PL 
B.II.b.1.a - Replacement or addition of a 
manufacturing site for the FP - Secondary packaging 
site 
B.II.b.2.c.1 - Change to importer, batch release 
arrangements and quality control testing of the FP - 
Replacement or addition of a manufacturer 
responsible for importation and/or batch release - 
Page 5/13 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Not including batch control/testing 
B.II.b.3.a - Change in the manufacturing process of 
the finished or intermediate product - Minor change 
in the manufacturing process 
IB/0022/G 
This was an application for a group of variations. 
12/10/2018 
n/a 
B.I.a.1.f - Change in the manufacturer of AS or of a 
starting material/reagent/intermediate for AS - 
Changes to quality control testing arrangements for 
the AS -replacement or addition of a site where 
batch control/testing takes place 
B.I.a.1.z - Change in the manufacturer of AS or of a 
starting material/reagent/intermediate for AS - Other 
variation 
B.I.b.1.z - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Other variation 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.I.c.1.a - Change in immediate packaging of the AS 
- Qualitative and/or quantitative composition 
B.I.d.1.a.4 - Stability of AS - Change in the re-test 
period/storage period - Extension or introduction of a 
re-test period/storage period supported by real time 
data 
B.I.a.2.z - Changes in the manufacturing process of 
the AS - Other variation 
B.I.a.4.z - Change to in-process tests or limits 
applied during the manufacture of the AS - Other 
Page 6/13 
 
 
 
 
 
 
 
 
 
variation 
B.I.b.1.z - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Other variation 
B.I.b.1.c - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Addition of a new 
specification parameter to the specification with its 
corresponding test method 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.I.b.2.c - Change in test procedure for AS or 
starting material/reagent/intermediate - Other 
changes to a test procedure for a reagent, which 
does not have a significant effect on the overall 
quality of the AS 
B.I.b.2.e - Change in test procedure for AS or 
starting material/reagent/intermediate - Other 
changes to a test procedure (including replacement 
or addition) for the AS or a starting 
material/intermediate 
R/0019 
Renewal of the marketing authorisation. 
31/05/2018 
26/07/2018 
SmPC, Annex 
Based on the review of data on quality, safety and efficacy, 
II, Labelling 
the CHMP considered that the benefit-risk balance of 
and PL 
Procysbi in the approved indication remains favourable and 
therefore recommended the renewal of the marketing 
authorisation with unlimited validity. 
Update of sections 4.2. 4.4 and 5.1 of the SmPC to include 
clarification on the WBC cystine assay and of section 4.2 of 
the SmPC to introduce clarification on the maximum 
Page 7/13 
 
 
 
 
 
 
 
T/0021 
Transfer of Marketing Authorisation 
12/04/2018 
24/05/2018 
SmPC, 
Labelling and 
PL 
II/0018 
B.II.d.1.e - Change in the specification parameters 
15/02/2018 
n/a 
and/or limits of the finished product - Change 
outside the approved specifications limits range 
IAIN/0020 
A.1 - Administrative change - Change in the name 
11/01/2018 
24/05/2018 
SmPC, 
and/or address of the MAH 
Labelling and 
PL 
IAIN/0017 
B.II.a.1.a - Change or addition of imprints, bossing 
23/11/2017 
15/12/2017 
SmPC and PL 
or other markings including replacement, or addition 
of inks used for product marking - Changes in 
imprints, bossing or other markings 
IAIN/0016 
A.1 - Administrative change - Change in the name 
05/09/2017 
15/12/2017 
SmPC, 
and/or address of the MAH 
Labelling and 
PL 
IA/0015/G 
This was an application for a group of variations. 
18/08/2017 
n/a 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
recommended daily dose and new PK data. In addition the 
MAH has taken the occasion to include some editorial 
changes throughout the Product Information and aligned 
the PI to the latest QRD template version 10.0. Annex II 
has been updated as result of the recent Marketing 
Authorisation Transfer. 
Page 8/13 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.II.b.3.a - Change in the manufacturing process of 
the finished or intermediate product - Minor change 
in the manufacturing process 
B.II.b.5.b - Change to in-process tests or limits 
applied during the manufacture of the finished 
product - Addition of a new test(s) and limits 
B.II.d.2.a - Change in test procedure for the finished 
product - Minor changes to an approved test 
procedure 
IA/0014/G 
This was an application for a group of variations. 
12/01/2017 
n/a 
A.4 - Administrative change - Change in the name 
and/or address of a manufacturer or an ASMF holder 
or supplier of the AS, starting material, reagent or 
intermediate used in the manufacture of the AS or 
manufacturer of a novel excipient 
A.5.b - Administrative change - Change in the name 
and/or address of a manufacturer/importer of the 
finished product, including quality control sites 
(excluding manufacturer for batch release) 
B.II.b.2.a - Change to importer, batch release 
arrangements and quality control testing of the FP - 
Replacement/addition of a site where batch 
control/testing takes place 
IAIN/0013 
A.1 - Administrative change - Change in the name 
11/01/2017 
15/12/2017 
SmPC, 
and/or address of the MAH 
Labelling and 
Page 9/13 
 
 
 
 
 
 
 
 
 
 
 
PSUSA/1987/
Periodic Safety Update EU Single assessment - 
09/06/2016 
n/a 
PRAC Recommendation - maintenance 
201510 
mercaptamine 
PL 
IB/0011 
B.II.f.1.d - Stability of FP - Change in storage 
05/01/2016 
18/11/2016 
SmPC and PL 
conditions of the finished product or the 
diluted/reconstituted product 
IAIN/0010 
B.II.b.2.c.1 - Change to importer, batch release 
15/12/2015 
18/11/2016 
Annex II and 
arrangements and quality control testing of the FP - 
PL 
Replacement or addition of a manufacturer 
responsible for importation and/or batch release - 
Not including batch control/testing 
IB/0009 
B.II.z - Quality change - Finished product - Other 
16/11/2015 
18/11/2016 
SmPC and PL 
variation 
IA/0008/G 
This was an application for a group of variations. 
31/07/2015 
n/a 
B.I.a.1.f - Change in the manufacturer of AS or of a 
starting material/reagent/intermediate for AS - 
Changes to quality control testing arrangements for 
the AS -replacement or addition of a site where 
batch control/testing takes place 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.I.b.2.a - Change in test procedure for AS or 
Page 10/13 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.II.b.2.a - Change to importer, batch release 
arrangements and quality control testing of the FP - 
Replacement/addition of a site where batch 
control/testing takes place 
B.II.b.2.a - Change to importer, batch release 
arrangements and quality control testing of the FP - 
Replacement/addition of a site where batch 
control/testing takes place 
B.II.d.2.a - Change in test procedure for the finished 
product - Minor changes to an approved test 
procedure 
B.II.e.7.b - Change in supplier of packaging 
components or devices (when mentioned in the 
dossier) - Replacement or addition of a supplier 
B.II.e.7.b - Change in supplier of packaging 
components or devices (when mentioned in the 
dossier) - Replacement or addition of a supplier 
IAIN/0007 
C.I.8.a - Introduction of or changes to a summary of 
20/05/2015 
n/a 
Pharmacovigilance system - Changes in QPPV 
(including contact details) and/or changes in the 
PSMF location 
II/0006/G 
This was an application for a group of variations. 
26/03/2015 
n/a 
B.II.d.1.e - Change in the specification parameters 
Page 11/13 
 
 
 
 
 
 
 
 
 
 
 
 
and/or limits of the finished product - Change 
outside the approved specifications limits range 
B.II.d.2.a - Change in test procedure for the finished 
product - Minor changes to an approved test 
procedure 
IAIN/0005 
B.II.b.2.c.1 - Change to importer, batch release 
14/10/2014 
22/10/2015 
Annex II and 
arrangements and quality control testing of the FP - 
PL 
Replacement or addition of a manufacturer 
responsible for importation and/or batch release - 
Not including batch control/testing 
N/0004 
Minor change in labelling or package leaflet not 
30/06/2014 
22/10/2015 
Labelling and 
connected with the SPC (Art. 61.3 Notification) 
PL 
IAIN/0003/G 
This was an application for a group of variations. 
10/04/2014 
n/a 
C.I.9.a - Changes to an existing pharmacovigilance 
system as described in the DDPS - Change in the 
QPPV and/or QPPV contact details and/or back-up 
procedure 
C.I.9.c - Changes to an existing pharmacovigilance 
system as described in the DDPS - Other change(s) 
to the DDPS that does not impact on the operation of 
the PhV system 
II/0002 
Change in the specification for the active substance 
20/03/2014 
n/a 
(mercaptamine bitartrate) to adjust the limit for 
assay of mercaptamine and the molar ratio of 
mercaptamine free base to tartaric acid. 
Page 12/13 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B.I.b.1.f - Change in the specification parameters 
and/or limits of an AS, starting 
material/intermediate/reagent - Change outside the 
approved specifications limits range for the AS 
IAIN/0001/G 
This was an application for a group of variations. 
25/10/2013 
n/a 
C.I.9.a - Changes to an existing pharmacovigilance 
system as described in the DDPS - Change in the 
QPPV and/or QPPV contact details and/or back-up 
procedure 
C.I.9.b - Changes to an existing pharmacovigilance 
system as described in the DDPS - Change(s) in the 
safety database and/or major contractual 
arrangements for the fulfilment of PhV obligations, 
and/or change of the site undergoing PhV activities 
B.I.b.2.a - Change in test procedure for AS or 
starting material/reagent/intermediate - Minor 
changes to an approved test procedure 
B.II.d.2.a - Change in test procedure for the finished 
product - Minor changes to an approved test 
procedure 
Page 13/13 
 
 
 
 
 
 
 
 
 
 
 
